159 related articles for article (PubMed ID: 38104690)
1. Rational design of a multivalent vaccine targeting arthropod-borne viruses using reverse vaccinology strategies.
Dhanushkumar T; Selvam PK; M E S; Vasudevan K; C GPD; Zayed H; Kamaraj B
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128753. PubMed ID: 38104690
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine.
Karkashan A
Front Immunol; 2024; 15():1395870. PubMed ID: 38799422
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus.
Nguyen TL; Kim H
Sci Rep; 2024 Mar; 14(1):5999. PubMed ID: 38472237
[TBL] [Abstract][Full Text] [Related]
5. Computational vaccinology guided design of multi-epitopes subunit vaccine designing against Hantaan virus and its validation through immune simulations.
Ghafoor D; Kousar A; Ahmed W; Khan S; Ullah Z; Ullah N; Khan S; Ahmed S; Khan Z; Riaz R
Infect Genet Evol; 2021 Sep; 93():104950. PubMed ID: 34089911
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics and Reverse Vaccinology Driven Predication of a Multi-epitope Vaccine against
Hussain Z; Hayat C; Shahab M; Sikandar R; Bibi H; Kamil A; Zheng G; Liang C
Curr Pharm Des; 2023; 29(19):1504-1515. PubMed ID: 37073655
[TBL] [Abstract][Full Text] [Related]
7. Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an
Ganji M; Bakhshi S; Ahmadi K; Shoari A; Moeini S; Ghaemi A
J Biomol Struct Dyn; 2024 Apr; 42(7):3426-3440. PubMed ID: 37190978
[TBL] [Abstract][Full Text] [Related]
8. Blueprint of epitope-based multivalent and multipathogenic vaccines: targeted against the dengue and zika viruses.
Sarkar B; Ullah MA; Araf Y; Das S; Hosen MJ
J Biomol Struct Dyn; 2021 Nov; 39(18):6882-6902. PubMed ID: 32772811
[TBL] [Abstract][Full Text] [Related]
9. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
[TBL] [Abstract][Full Text] [Related]
10. Design of multi-epitope based vaccine against
Nayak SS; Sethi G; Ramadas K
J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
[TBL] [Abstract][Full Text] [Related]
11. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
12. Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus.
Moin AT; Patil RB; Tabassum T; Araf Y; Ullah MA; Snigdha HJ; Alam T; Alvey SA; Rudra B; Mina SA; Akter Y; Zhai J; Zheng C
Microbiol Spectr; 2022 Oct; 10(5):e0115122. PubMed ID: 36094198
[TBL] [Abstract][Full Text] [Related]
13. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
[TBL] [Abstract][Full Text] [Related]
14. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
Khan NT; Zinnia MA; Islam ABMMK
J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
[TBL] [Abstract][Full Text] [Related]
15. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
[TBL] [Abstract][Full Text] [Related]
16. Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens.
Ponne S; Kumar R; Vanmathi SM; Brilhante RSN; Kumar CR
Vaccine; 2024 Apr; 42(10):2503-2518. PubMed ID: 38523003
[TBL] [Abstract][Full Text] [Related]
17. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
18. Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit vaccine designing for immune response reinforcement against
Khan S; Ali SS; Zaheer I; Saleem S; Ziaullah ; Zaman N; Iqbal A; Suleman M; Wadood A; Rehman AU; Khan A; Khan A; Wei DQ
J Biomol Struct Dyn; 2022 Feb; 40(2):833-847. PubMed ID: 32928063
[No Abstract] [Full Text] [Related]
19. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
Ullah MA; Sarkar B; Islam SS
Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive screening of the whole proteome of hantavirus and designing a multi-epitope subunit vaccine for cross-protection against hantavirus: Structural vaccinology and immunoinformatics study.
Abdulla F; Nain Z; Hossain MM; Syed SB; Ahmed Khan MS; Adhikari UK
Microb Pathog; 2021 Jan; 150():104705. PubMed ID: 33352214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
